lu ag09222
mAbexperimental
Clinical trial activity
6 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Jul 15, 2021 (NCT04976309)
Timeline
Indications
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06578585 | Phase 1 | Sep 13, 2024 | Lundbeck |
| NCT06323928 | Phase 2 | Apr 1, 2024 | Lundbeck |
| NCT05304910 | Phase 1 | Mar 18, 2022 | Lundbeck |
| NCT05133323 | Phase 2 | Nov 11, 2021 | Lundbeck |
| NCT05126316 | Phase 1 | Nov 1, 2021 | Lundbeck |
| NCT04976309 | Phase 1 | Jul 15, 2021 | Lundbeck |
Showing 6 of 6 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Lundbeck | For profit | 6 | 6 | 2 | 2021 |
1 organizations
Page 1 / 1